EUVIMEDEUVIMED entdecken
Crossref

Clinical Characteristics and Outcomes of Pediatric Systemic Anaplastic Large Cell Lymphoma

Juan-Manuel Morón-Ocaña iD, Pablo Monsalve-Sosa, María-Luisa Martínez-Barranca, Isabel-María Coronel-Pérez, Amalia Pérez-Gil

Pediatric Dermatology · 2025

DOI: 10.1111/pde.15850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Juan-Manuel Morón-Ocaña und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology of Hospital, Universitario Virgen de Valme, Sevilla, Spain. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic, Skin Neoplasms. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives Anaplastic large cell lymphomas (ALCLs) present unique challenges due to their clinical and genetic heterogeneity. This study investigated the clinical characteristics of children diagnosed with systemic ALCL.

Methods

Retrospective data from 14 pediatric patients diagnosed with systemic ALCL at Valme University Hospital were studied. Demographic, clinical, and treatment data were collected and statistically analyzed.

Results

The mean age at diagnosis was 8.5 years, with a male predominance (78.6%). Cutaneous presentation occurred in 35.7% of cases, with characteristic rapidly growing subcutaneous nodules. B symptoms were present in 57.1% of patients, while 100% exhibited nodal involvement. Visceral and bone marrow involvement was observed in 71.4% and 7.1% of patients, respectively. Central nervous system (CNS) involvement was absent. Anaplastic lymphoma kinase ( ALK ) rearrangement was positive in all cases. Anthracycline‐based chemotherapy resulted in 100% 5‐ and 10‐year overall survival rates.

Conclusions

Systemic ALCL in children often presents with advanced‐stage disease, with cutaneous involvement in a significant proportion of cases. Prompt recognition of skin lesions is vital to expedite diagnosis and treatment initiation, ultimately improving patient outcomes. This study underscores the importance of vigilance and early intervention in managing pediatric ALCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large-Cell, AnaplasticSkin NeoplasmsHumansMaleChildFemaleRetrospective StudiesChild, PreschoolAdolescentAnaplastic Lymphoma KinaseInfantSurvival Rate

Stichwörter der Autor:innen

ALK‐positiveanaplastic large cell lymphomacutaneouspediatric

Substanzen

Anaplastic Lymphoma Kinase

Autor:innen und Institutionen

  • Department of Dermatology of Hospital, Universitario Virgen de Valme, Sevilla, Spain.
  • Department of Pathology of Hospital, Universitario Virgen del Rocío, Sevilla, Spain.

ORCID-Profile: Juan-Manuel Morón-Ocaña

Zitieren

APA

Morón-Ocaña, J. M., Monsalve-Sosa, P., Martínez-Barranca, M. L., Coronel-Pérez, I. M., & Pérez-Gil, A. (2025). Clinical Characteristics and Outcomes of Pediatric Systemic Anaplastic Large Cell Lymphoma. Pediatric Dermatology. https://doi.org/10.1111/pde.15850

Vancouver

Morón-Ocaña JM, Monsalve-Sosa P, Martínez-Barranca ML, Coronel-Pérez IM, Pérez-Gil A. Clinical Characteristics and Outcomes of Pediatric Systemic Anaplastic Large Cell Lymphoma. Pediatric Dermatology. 2025. doi:10.1111/pde.15850

BibTeX
@article{MornOcaa2025,
  author = {Morón-Ocaña, Juan-Manuel and Monsalve-Sosa, Pablo and Martínez-Barranca, María-Luisa and Coronel-Pérez, Isabel-María and Pérez-Gil, Amalia},
  title = {Clinical Characteristics and Outcomes of Pediatric Systemic Anaplastic Large Cell Lymphoma},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.15850}
}
Kostenlos starten →